Corneal Physician Bulletin: HCP Cureblindness Acquires SightLife International
HCP Cureblindness acquired the SightLife International Program, the global division of the broader SightLife organization, with full integration of systems, programs, and brand, according to a press release. By combining the regions where each organization serves, their work can go farther and faster toward eliminating blindness due to cataracts and corneal blindness – worldwide, which together impact nearly 70 million people globally, according to the press release.
“Together, our respective expertise will have a substantial and long-term impact on the world’s most underserved communities, helping to enable local eye care access for the future,” points out HCP Cureblindness CEO, K-T Overbey, in the press release. “Building on our shared commitment to training, while also combining HCP Cureblindness’ deep expertise in specialized care delivery and infrastructure development with SightLife International’s expertise in primary care and policy and advocacy, we will ensure millions of men, women, and children across Asia and Africa have access to the eye care they need to thrive.”
Established in 1995, HCP Cureblindness brings eye care to people in underserved areas of the world with a continual focus on training local personnel, according to the press release. With a network of implementing partners in over 20 countries, the organization has provided over 1.19 million sight-restoring surgeries and 13.3 million screenings and basic treatments, has trained over 19,000 eye health professionals, and has established 5 eye hospitals.
SightLife International is a global health nonprofit organization dedicated to eliminating corneal blindness. It has played a significant role in restoring sight and preventing blindness in more than 225,000 individuals globally and has provided clinical training for more than 7,000 health care providers, according to the press release. SightLife International appeared in the April 2021 issue of Cornea Physician. For the full article, see bit.ly/3lNJTcY. CP